Bengaluru, India

Sarang Bani

This inventor holds 14 USPTO granted patents and 7 published patent applications, plus 5 CIPO patents and 9 EPO patents. Top assignees: Sami Labs Limited, Sami-Sabinsa Group Limited, Semi Labs Limited. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sarang Bani. Retrieved from https://idiyas.com/inventor/sarang-bani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: **Sarang Bani: Innovator in Health Solutions from Bengaluru**

Introduction

Sarang Bani is a prolific inventor based in Bengaluru, India, who has made significant contributions to the field of healthcare through his innovations. With a remarkable portfolio of 14 patents, Sarang's work focuses primarily on compositions that address critical health issues, particularly in relation to polycystic ovary syndrome (PCOS) and chronic obstructive pulmonary disease (COPD).

Latest Patents

One of Sarang Bani's latest patents is centered around compositions for the management of polycystic ovary syndrome. This innovative invention introduces compositions that include bisdemethoxycurcumin and outlines methods for managing PCOS and its associated conditions such as hormonal imbalance, obesity, hypothyroidism, and cardiovascular complications. The patented composition, comprising 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin, and 10-50% w/w curcumin, offers a therapeutic approach to managing this complex condition.

Another significant patent focuses on managing chronic obstructive pulmonary disease. It reveals a composition consisting of at least 20% w/w bisdemethoxycurcumin aimed at regenerating alveolar cells that are damaged during emphysematous conditions. The composition, which also contains 10-35% w/w demethoxycurcumin and 10-45% w/w curcumin, proves to be exceptionally beneficial for treating COPD and acute respiratory distress syndrome (ARDS), especially amid viral infections like COVID-19.

Career Highlights

Throughout his career, Sarang has collaborated with notable organizations, including Sami Labs Limited and Sami-Sabinsa Group Limited. His work in these companies has allowed him to push the boundaries of innovation in health-related solutions, making impactful advancements in therapeutic compositions.

Collaborations

Sarang has worked alongside skilled professionals such as Kalyanam Nagabhushanam and Anjali Pandey. These collaborations have further enhanced his ability to innovate and create effective solutions in the health domain.

Conclusion

Sarang Bani stands out as an influential inventor whose commitment to addressing significant health challenges through his patents demonstrates the potential of innovative ingredients in therapeutics. His work not only showcases the intersection of science and health but also paves the way for better management of chronic conditions, ultimately aiming to improve the quality of life for many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…